Clinical Trials Logo
  1. Home
  2. Recurrent Pterygium
  3. NCT01744756

Subconjunctival Bevacizumab and Recurrent Pterygium — BRP  

Recurrent Pterygium Clinical Trial

Official title:
Interventional Trial of Subconjunctival Bevacizumab in Recurrent Pterygium

Clinical Trial Summary

A study to research whether subconjunctival bevacizumab injection may potentially suppress neovascularization in pterygium, retarding and decreasing the size of recurrent pterygium.

Clinical Trial Description

1. Pacients with recurrent pterygium

2. Anti-VEGF therapy -Bevacizumab ;

Study Design

Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT01744756
Study type Interventional
Source Instituto de Olhos de Goiania
Contact
Status Completed
Phase Phase 2/Phase 3
Start date February 2012
Completion date September 2012
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT02486484 - Ziv-aflibercept in Ocular Disease Requiring Anti-VEGF Injection Phase 2
Completed NCT02007174 - Bevacizumab Injection for Recurrent Pterygium N/A
Completed NCT05362253 - Micro-Conjunctival Autografting Combined With Amniotic Membrane Transplantation Treating Recurrent Pterygium Trial N/A
Active, not recruiting NCT02530801 - Strategies for Management of Recurrent Pterygium Phase 4
Recruiting NCT04463901 - Conjunctival Autograft or Limbal Conjunctival Autograft for Recurrent Pterygium Using Mitomycin C N/A
Completed NCT02059837 - Clinical Analysis of Recurrence Patterns Following Conjunctival Autografts for Pterygium Surgery N/A
Completed NCT01319721 - Recurrent Pterygium Surgery Using Mitomycin C With Limbal Conjunctival or Amniotic Membrane N/A